Good At

Single-port and subxiphoid single-port thoracoscopic and single-port robot-assisted surgery for the treatment of various lung diseases such as lung cancer, pulmonary nodules, and mediastinal tumors. Comprehensive treatment of mediastinal tumors based on surgery.

Introduction

Single-port and subxiphoid single-port thoracoscopic and single-port robot-assisted surgery for the treatment of various lung diseases such as lung cancer, pulmonary nodules, and mediastinal tumors. Comprehensive treatment of mediastinal tumors is mainly based on surgery. In 2011, he won the Silver Snake Award Nomination Award, the highest honorary award for young talents in the health system of Shanghai City. In 2015, he won the only highest award in the AME-Medtronic National Thoracoscopic Lung Resection Video Competition-the Excellence Award. In 2013, one of the earliest experts in China to carry out single-port thoracoscopic lobectomy. In 2014, the first subxiphoid single-port thoracoscopic lobectomy was carried out in China. Relevant surgical experience and videos have been introduced and demonstrated in many international and domestic conferences. Subxiphoid thoracoscopic surgery is suitable for the treatment of early lung diseases such as lung cancer. Since it does not damage the ribs and intercostal nerves, subxiphoid single-port thoracoscopic surgery greatly reduces short-term and long-term postoperative wound pain, skin numbness and other problems. It is especially suitable for early lung cancer, bilateral pulmonary nodules, pulmonary bullae, bilateral pneumothorax and other diseases. Moreover, bilateral lung lesions can be treated through an incision of only about 3-4CM, avoiding the pain of bilateral thoracotomy during routine surgery.